GRID2 Gene Spinocerebellar Ataxia Type 18 Autosomal Recessive Genetic Test
Test Name: GRID2 Gene Spinocerebellar Ataxia Type 18 Autosomal Recessive Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for GRID2 Gene Spinocerebellar Ataxia Type 18, autosomal recessive NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GRID2 Gene Spinocerebellar Ataxia Type 18, autosomal recessive.
Test Details
GRID2 gene spinocerebellar ataxia type 18 is a specific type of ataxia that is caused by mutations in the GRID2 gene. This condition is inherited in an autosomal recessive manner, which means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder.
To diagnose spinocerebellar ataxia type 18, a genetic test called Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput method that allows for the rapid sequencing of large amounts of DNA. This test can identify mutations or variations in the GRID2 gene that are associated with spinocerebellar ataxia type 18.
NGS genetic testing involves collecting a sample of the individual’s DNA, usually through a blood or saliva sample. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variations in the GRID2 gene. If a mutation is found, it can confirm a diagnosis of spinocerebellar ataxia type 18.
Genetic testing can be useful in diagnosing spinocerebellar ataxia type 18, as it can provide a definitive diagnosis and help guide treatment and management options. It can also be helpful for family planning purposes, as it can determine if an individual is a carrier of the mutated gene and at risk of passing it on to their children.
It is important to note that genetic testing for spinocerebellar ataxia type 18 should be performed by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and support throughout the testing process.
| Test Name | GRID2 Gene Spinocerebellar ataxia type 18 autosomal recessive Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GRID2 Gene Spinocerebellar ataxia type 18, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GRID2 Gene Spinocerebellar ataxia type 18, autosomal recessive |
| Test Details |
GRID2 gene spinocerebellar ataxia type 18 is a specific type of ataxia that is caused by mutations in the GRID2 gene. This condition is inherited in an autosomal recessive manner, which means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. To diagnose spinocerebellar ataxia type 18, a genetic test called Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput method that allows for the rapid sequencing of large amounts of DNA. This test can identify mutations or variations in the GRID2 gene that are associated with spinocerebellar ataxia type 18. NGS genetic testing involves collecting a sample of the individual’s DNA, usually through a blood or saliva sample. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variations in the GRID2 gene. If a mutation is found, it can confirm a diagnosis of spinocerebellar ataxia type 18. Genetic testing can be useful in diagnosing spinocerebellar ataxia type 18, as it can provide a definitive diagnosis and help guide treatment and management options. It can also be helpful for family planning purposes, as it can determine if an individual is a carrier of the mutated gene and at risk of passing it on to their children. It is important to note that genetic testing for spinocerebellar ataxia type 18 should be performed by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and support throughout the testing process. |
